Answers are grounded in this paper and cite their sources.
Oxylipins, a diverse family of oxidized lipids derived from mono- and polyunsaturated fatty acids, are increasingly recognized as key mediators in redox biology and inflammation. They are produced through enzymatic pathways involving cyclooxygenases (COX), lipoxygenases (LOX), cytochrome P450s (CYP), and soluble epoxide hydrolase (sEH), as well as through non-enzymatic mechanisms including singlet oxygen and free radical-mediated lipid peroxidation. Advances in mass spectrometry, particularly targeted LC-MS/MS approaches, have enabled sensitive and selective quantification of oxylipins in complex biological matrices. This article provides a focused overview of oxylipin alterations in neurodegenerative disorders (Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis), obesity, infectious diseases, chronic pain conditions, and inflammatory skin disorders.
No takes yet. Share an insight, caveat, or question.
Diniz et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: